Pre-order Enquiry
Request Free Sample
Global (United States, European Union and China) Neurological Disorder Drugs Market Research Report 2019-2025
SKU ID : QYR-14529445 | Publishing Date : 06-Aug-2019 | No. of pages : 114
Detailed TOC of Global (United States, European Union and China) Neurological Disorder Drugs Market Research Report 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Neurological Disorder Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Antipsychotic
1.3.3 Hypnotic & Sedative
1.3.4 Analgesics
1.3.5 Anticoagulants
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Neurological Disorder Drugs Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurological Disorder Drugs Market Size
2.1.1 Global Neurological Disorder Drugs Revenue 2014-2025
2.1.2 Global Neurological Disorder Drugs Sales 2014-2025
2.2 Neurological Disorder Drugs Growth Rate by Regions
2.2.1 Global Neurological Disorder Drugs Sales by Regions 2014-2019
2.2.2 Global Neurological Disorder Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Neurological Disorder Drugs Sales by Manufacturers
3.1.1 Neurological Disorder Drugs Sales by Manufacturers 2014-2019
3.1.2 Neurological Disorder Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Neurological Disorder Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Neurological Disorder Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Neurological Disorder Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Neurological Disorder Drugs Price by Manufacturers
3.4 Key Manufacturers Neurological Disorder Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Neurological Disorder Drugs Market
3.6 Key Manufacturers Neurological Disorder Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antipsychotic Sales and Revenue (2014-2019)
4.1.2 Hypnotic & Sedative Sales and Revenue (2014-2019)
4.1.3 Analgesics Sales and Revenue (2014-2019)
4.1.4 Anticoagulants Sales and Revenue (2014-2019)
4.1.5 Others Sales and Revenue (2014-2019)
4.2 Global Neurological Disorder Drugs Sales Market Share by Type
4.3 Global Neurological Disorder Drugs Revenue Market Share by Type
4.4 Neurological Disorder Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Neurological Disorder Drugs Sales by Application
6 United States
6.1 United States Neurological Disorder Drugs Breakdown Data by Company
6.2 United States Neurological Disorder Drugs Breakdown Data by Type
6.3 United States Neurological Disorder Drugs Breakdown Data by Application
7 European Union
7.1 European Union Neurological Disorder Drugs Breakdown Data by Company
7.2 European Union Neurological Disorder Drugs Breakdown Data by Type
7.3 European Union Neurological Disorder Drugs Breakdown Data by Application
8 China
8.1 China Neurological Disorder Drugs Breakdown Data by Company
8.2 China Neurological Disorder Drugs Breakdown Data by Type
8.3 China Neurological Disorder Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Neurological Disorder Drugs Breakdown Data by Company
9.2 Rest of World Neurological Disorder Drugs Breakdown Data by Type
9.3 Rest of World Neurological Disorder Drugs Breakdown Data by Application
9.4 Rest of World Neurological Disorder Drugs Breakdown Data by Countries
9.4.1 Rest of World Neurological Disorder Drugs Sales by Countries
9.4.2 Rest of World Neurological Disorder Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novartis AG
10.1.1 Novartis AG Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.1.4 Neurological Disorder Drugs Product Introduction
10.1.5 Novartis AG Recent Development
10.2 GlaxoSmithKline plc
10.2.1 GlaxoSmithKline plc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.2.4 Neurological Disorder Drugs Product Introduction
10.2.5 GlaxoSmithKline plc Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.3.4 Neurological Disorder Drugs Product Introduction
10.3.5 Merck & Co. Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.4.4 Neurological Disorder Drugs Product Introduction
10.4.5 Bayer AG Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.5.4 Neurological Disorder Drugs Product Introduction
10.5.5 AstraZeneca Recent Development
10.6 Boehringer Ingelheim GmbH
10.6.1 Boehringer Ingelheim GmbH Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.6.4 Neurological Disorder Drugs Product Introduction
10.6.5 Boehringer Ingelheim GmbH Recent Development
10.7 Teva Pharmaceutical
10.7.1 Teva Pharmaceutical Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Neurological Disorder Drugs
10.7.4 Neurological Disorder Drugs Product Introduction
10.7.5 Teva Pharmaceutical Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Neurological Disorder Drugs Sales Channels
11.2.2 Neurological Disorder Drugs Distributors
11.3 Neurological Disorder Drugs Customers
12 Market Forecast
12.1 Global Neurological Disorder Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Neurological Disorder Drugs Sales Forecast by Type
12.3 Global Neurological Disorder Drugs Sales Forecast by Application
12.4 Neurological Disorder Drugs Forecast by Regions
12.4.1 Global Neurological Disorder Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Neurological Disorder Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global (United States, European Union and China) Neurological Disorder Drugs Market Research Report 2019-2025
List of Tables and FiguresFigure Neurological Disorder Drugs Product Picture
Table Neurological Disorder Drugs Key Market Segments
Table Major Manufacturers Neurological Disorder Drugs Covered in This Report
Table Global Neurological Disorder Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Neurological Disorder Drugs Sales Market Shar by Type 2014-2025
Figure Antipsychotic Figures
Table Major Manufacturers of Antipsychotic
Figure Hypnotic & Sedative Figures
Table Major Manufacturers of Hypnotic & Sedative
Figure Analgesics Figures
Table Major Manufacturers of Analgesics
Figure Anticoagulants Figures
Table Major Manufacturers of Anticoagulants
Figure Others Figures
Table Major Manufacturers of Others
Table Global Neurological Disorder Drugs Market Share by Application 2019-2025 (K Units)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Neurological Disorder Drugs Report Years Considered
Figure Global Neurological Disorder Drugs Market Size 2014-2025 (Million US$)
Figure Global Neurological Disorder Drugs Sales 2014-2019 (K Units)
Table Global Neurological Disorder Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Neurological Disorder Drugs Sales by Regions 2014-2019 (K Units)
Table Global Neurological Disorder Drugs Sales Market Share by Regions 2014-2019
Figure Global Neurological Disorder Drugs Sales Market Share by Regions 2014-2019
Figure Global Neurological Disorder Drugs Sales Market Share by Regions in 2019
Table Global Neurological Disorder Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Neurological Disorder Drugs Revenue Market Share by Regions 2014-2019
Figure Global Neurological Disorder Drugs Revenue Market Share by Regions 2014-2019
Figure Global Neurological Disorder Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Neurological Disorder Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Neurological Disorder Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Neurological Disorder Drugs Sales Share by Manufacturers in 2019
Table Neurological Disorder Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Neurological Disorder Drugs Revenue Share by Manufacturers (2014-2019)
Figure Neurological Disorder Drugs Value Share by Manufacturers in 2019
Table Global Neurological Disorder Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Neurological Disorder Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Neurological Disorder Drugs Plants/Factories Distribution
Table Key Manufacturers Neurological Disorder Drugs Area Served
Table Date of Key Manufacturers Enter into Neurological Disorder Drugs Market
Table Key Manufacturers Neurological Disorder Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Antipsychotic Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Hypnotic & Sedative Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Analgesics Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Anticoagulants Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Others Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Neurological Disorder Drugs Sales by Type (2014-2019) (K Units)
Table Global Neurological Disorder Drugs Sales Share by Type (2014-2019)
Figure Global Neurological Disorder Drugs Sales Market Share by Type (2014-2019)
Figure Global Neurological Disorder Drugs Sales Market Share by Type in 2018
Table Global Neurological Disorder Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Neurological Disorder Drugs Revenue Share by Type (2014-2019)
Figure Global Neurological Disorder Drugs Revenue Market Share by Type (2014-2019)
Figure Global Neurological Disorder Drugs Revenue Market Share by Type in 2018
Table Neurological Disorder Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Neurological Disorder Drugs Sales by Application (2014-2019) (K Units)
Table Global Neurological Disorder Drugs Sales Share by Application (2014-2019)
Figure Global Sales Neurological Disorder Drugs Market Share by Application (2014-2019)
Figure Global Sales Neurological Disorder Drugs Market Share by Application (2014-2019)
Figure United States Neurological Disorder Drugs Sales Growth Rate 2014-2019 (K Units)
Figure United States Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Neurological Disorder Drugs Sales by Company (2014-2019) (K Units)
Table United States Neurological Disorder Drugs Sales Market Share by Company (2014-2019)
Figure United States Neurological Disorder Drugs Sales Market Share by Company in 2019
Table United States Neurological Disorder Drugs Sales by Type (2014-2019) (K Units)
Table United States Neurological Disorder Drugs Sales Market Share by Type (2014-2019)
Figure United States Neurological Disorder Drugs Market Share by Type in 2019
Table United States Neurological Disorder Drugs Sales by Application (2014-2019) (K Units)
Table United States Neurological Disorder Drugs Sales Market Share by Application (2014-2019)
Figure United States Neurological Disorder Drugs Market Share by Application in 2019
Figure European Union Neurological Disorder Drugs Sales Growth Rate 2014-2019 (K Units)
Figure European Union Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Neurological Disorder Drugs Sales by Company (2014-2019) (K Units)
Table European Union Neurological Disorder Drugs Sales Market Share by Company (2014-2019)
Figure European Union Neurological Disorder Drugs Sales Market Share by Company in 2019
Table European Union Neurological Disorder Drugs Sales by Type (2014-2019) (K Units)
Table European Union Neurological Disorder Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Neurological Disorder Drugs Market Share by Type
Table European Union Neurological Disorder Drugs Sales by Application (2014-2019) (K Units)
Table European Union Neurological Disorder Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Neurological Disorder Drugs Market Share by Application
Figure China Neurological Disorder Drugs Sales Growth Rate 2014-2019 (K Units)
Figure China Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Neurological Disorder Drugs Sales by Company (2014-2019) (K Units)
Table China Neurological Disorder Drugs Sales Market Share by Company (2014-2019)
Figure China Neurological Disorder Drugs Sales Market Share by Company in 2019
Table China Neurological Disorder Drugs Sales by Type (2014-2019) (K Units)
Table China Neurological Disorder Drugs Sales Market Share by Type (2014-2019)
Figure China Neurological Disorder Drugs Market Share by Type in 2019
Table China Neurological Disorder Drugs Sales by Application (2014-2019) (K Units)
Table China Neurological Disorder Drugs Sales Market Share by Application (2014-2019)
Figure China Neurological Disorder Drugs Market Share by Application in 2019
Figure Rest of World Neurological Disorder Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Neurological Disorder Drugs Sales by Company (2014-2019) (K Units)
Table Rest of World Neurological Disorder Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Neurological Disorder Drugs Sales Market Share by Company in 2019
Table Rest of World Neurological Disorder Drugs Sales by Type (2014-2019) (K Units)
Table Rest of World Neurological Disorder Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Neurological Disorder Drugs Market Share by Type in 2019
Table Rest of World Neurological Disorder Drugs Sales by Application (2014-2019) (K Units)
Table Rest of World Neurological Disorder Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Neurological Disorder Drugs Market Share by Application in 2019
Table Rest of World Neurological Disorder Drugs Sales by Countries (2014-2019) (K Units)
Table Rest of World Neurological Disorder Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Neurological Disorder Drugs Sales Market Share by Countries in 2019
Table Rest of World Neurological Disorder Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Neurological Disorder Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Neurological Disorder Drugs Revenue Market Share by Countries in 2019
Figure Japan Neurological Disorder Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Neurological Disorder Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Neurological Disorder Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Neurological Disorder Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure India Neurological Disorder Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Neurological Disorder Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Neurological Disorder Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Neurological Disorder Drugs Revenue Growth Rate (2014-2019) (K Units)
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table Novartis AG Neurological Disorder Drugs Sales Market Share in Global Market
Table Novartis AG Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Description and Business Overview
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales Market Share in Global Market
Table GlaxoSmithKline plc Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Description and Business Overview
Table Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table Merck & Co. Neurological Disorder Drugs Sales Market Share in Global Market
Table Merck & Co. Recent Development
Table Bayer AG Company Details
Table Bayer AG Description and Business Overview
Table Bayer AG Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table Bayer AG Neurological Disorder Drugs Sales Market Share in Global Market
Table Bayer AG Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table AstraZeneca Neurological Disorder Drugs Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Description and Business Overview
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim GmbH Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Description and Business Overview
Table Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Neurological Disorder Drugs Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Neurological Disorder Drugs Sales Market Share in Global Market
Table Teva Pharmaceutical Recent Development
Figure Neurological Disorder Drugs Value Chain
Table Neurological Disorder Drugs Distributors List
Table Neurological Disorder Drugs Customers List
Table Global Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Neurological Disorder Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Neurological Disorder Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Neurological Disorder Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Neurological Disorder Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Neurological Disorder Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure United States Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure European Union Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure China Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure Korea Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure India Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Neurological Disorder Drugs Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Neurological Disorder Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global (United States, European Union and China) Neurological Disorder Drugs Market Research Report 2019-2025
Novartis AGGlaxoSmithKline plc
Merck & Co.
Bayer AG
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceutical
Request Sample
Request Discount
